SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No. 1
North American Vaccine, Inc.
----------------------------------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------------------------------------
(Title of Class of Securities)
657201109
-----------------------------------------------------------------------
(CUSIP NUMBER)
Delphi Asset Management, Inc.
485 Madison Avenue, 20th Floor
New York, New York 10022
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
- with copies to -
Michael G. Tannenbaum, Esq.
Tannenbaum Helpern Syracuse & Hirschtritt LLP
900 Third Avenue - 13th Floor
New York, New York 10022
(212) 508-6700
December 31, 1999
(Date of event which requires
filing of this statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1-(b)
|X| Rule 13d-1-(c)
|_| Rule 13d-1-(d)
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act.
Page 1 of 6 Pages
<PAGE>
CUSIP No. 657201109
1. Names of Reporting Persons
I.R.S. Identification Nos. of Above Persons (entities only)
Delphi Asset Management, Inc. 13-3996964 which reflects a change of name of the
entity that formerly filed as Delphi Asset Management.
2. Check the Appropriate Box if a Member of a Group (See Instructions)
a. |_|
b. |_|
3. SEC Use Only
4. Citizenship or Place of Organization: New York
Number of Shares 5. Sole Voting Power 1,622,300 shares
Beneficially
Owned by 6. Shared Voting Power 0
Each
Reporting 7. Sole Dispositive Power 2,277,700 shares
Person
With 8. Shared Dispositive Power 0
9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,277,700 shares
10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
11. Percent of Class Represented by Amount in Row 9 6.9351% of Common Stock
12. Type of Reporting Person (See Instructions) IA, CO
Page 2 of 6 Pages
<PAGE>
CUSIP No. 657201109
Item 1(a) Name of Issuer:
North American Vaccine, Inc.
Item 1(b) Address of Issuer:
12103 Indian Creek Court
Beltsville, MD 20705
Item 2(a) Name of Person Filing:
Delphi Asset Management, Inc. ("Delphi")
Item 2(b) Address of Principal Business Office or, if none, Residence:
485 Madison Avenue, 20th Floor
New York, New York 10022
Item 2(c) Citizenship:
New York Corporation
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
657201109
Item 3 If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or
13d-2(c) promulgated under the Securities Exchange Act of 1934, check
whether the filing person is a:
Page 3 of 6 Pages
<PAGE>
CUSIP No. 657201109
a. |_| Broker or dealer registered under Section 15 of the Act,
b. |_| Bank as defined in Section 3(a)(6) of the Act,
c. |_| Insurance Company as defined in Section 3(a)(19) of the Act,
d. |_| Investment Company registered under Section 8 of the Investment Company
Act,
e. |_| Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E),
f. |_| Employee Benefit Plan, or Endowment Fund in accordance with Rule
13d-1(b)(1)(ii)(F),
g. |_| Parent Holding Company or Control Person, in accordance with
Rule 13d-1(b)(ii)(G); (Note: see Item 7)
h. |_| A savings association as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);
i. |_| A church plan that is excluded from the
definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940;
j. |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Sec. 240.13d-1(c), check
this box |X|.
Item 4 Ownership:
(a) Amount Beneficially Owned:
As of December 31, 1999, 2,277,700 shares were beneficially
owned by Delphi on behalf of a number of private investment
vehicles and managed accounts.
(b) Percent of Class: 6.9351%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
1,622,300 Shares
(ii) shared power to vote or direct the vote:
0
Page 4 of 6 Pages
<PAGE>
CUSIP No. 657201109
(iii) sole power to dispose or to direct the disposition of:
2,277,700 shares
(iv) shared power to dispose or direct the disposition of:
0
Item 5 Ownership of Five Percent or Less of a Class:
- ------
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following |_|
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
- ------
Not applicable
Item 7 Identification and Classification of the Subsidiary which Acquired the
- ------
Security Being Reported on By the Parent Holding Company:
Not applicable
Item 8 Identification and Classification of Members of the Group:
- ------
Not applicable
Item 9 Notice of Dissolution of Group:
- ------
Not applicable
Item 10 Certification:
- -------
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the insurer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
Page 5 of 6 Pages
<PAGE>
CUSIP No. 657201109
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 11, 2000
- -------------------------------------------------------------------------------
Date
/s/ Marc Keller
- -------------------------------------------------------------------------------
Signature
Marc Keller, Senior Managing Director
- -------------------------------------------------------------------------------
Name/Title
Page 6 of 6 Pages
<PAGE>